Assignee
DEISSEROTH ALBERT B
US·8 granted patents·1 pending application·54 citations·filing 2003–2019
Top patents by PatentIndex Score
9 records- 0192US8119117B2Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunityDEISSEROTH ALBERT B·Filed 2003·Granted Feb 21, 2012·37 cites·50 claims
- 0289US8236295B1Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responsesDEISSEROTH ALBERT B·Filed 2012·Granted Aug 7, 2012·9 cites·9 claims
- 0386US10130667B1TAA/ecdCD40L oncolytic virusDEISSEROTH ALBERT B·Filed 2016·Granted Nov 20, 2018·3 cites·3 claims
- 0483US8540979B2Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion proteinDEISSEROTH ALBERT B·Filed 2012·Granted Sep 24, 2013·4 cites·6 claims
- 0577US10383932B2Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cellsDEISSEROTH ALBERT B·Filed 2016·Granted Aug 20, 2019·1 cites·15 claims
- 0668US10835589B2Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD40L/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cellsDEISSEROTH ALBERT B·Filed 2019·Granted Nov 17, 2020·0 cites·15 claims
- 0747US9889188B1Ebola virus composition/vaccineDEISSEROTH ALBERT B·Filed 2016·Granted Feb 13, 2018·0 cites·10 claims
- 0847US2014127252A1Tularemia-taa/cd40l vaccineDEISSEROTH ALBERT B·Filed 2014·Application pending·0 cites
- 0944US10149899B1Composition and method against C-difficileDEISSEROTH ALBERT B·Filed 2016·Granted Dec 11, 2018·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when DEISSEROTH ALBERT B files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →